Dr. Lal Pathlabs, 539524, LALPATHLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

32,307.15
59.62
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

31,397.62
1.06%
12.37

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.72
5.77
7.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.66
6.89
5.13

PAT CAGR (%)

10 Years
5 Years
3 Years

12.56
7.92
12.16

P:E (Median)

8 Years
5 Years
3 Years

60.89
62.62
56.48

P:BV (Average)

8 Years
5 Years
3 Years

13.04
12.86
11.49

EV:EBITDA (Average)

8 Years
5 Years
3 Years

34.18
33.30
31.24

Earnings Forecasts:

(Updated: 01-08-2026)

Description 2026 2027 2028 2029
Adj EPS 60 6 14.75 30.74
P/E Ratio 32.13 321.33 130.71 62.72
Revenue 46.73 40.77 33.4 2736.82
EBITDA 3136.93 3539.06 3945.43 774.84
Net Income 883.45 1006.72 1124.01 512.67
ROA 594.82 690.19 788.79 17.66
P/B Ratio -1.20 -0.96 -0.78 13.15
ROE 9.8 8.22 7.06 22.03
FCFF 21.96 22.6 22.83 473.56
FCFF Yield 605.25 709.86 837.55 1.78
Net Debt 2.28 2.67 3.15 -1359.08
BVPS -1608.57 -2018.28 -2485.2 146.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 764.40 640.70 19.31% 675.20 577.20 16.98% 632.10 569.20 11.05% 699.60 630.90 10.89%
Expenses 525.90 457.30 15.00% 493.70 418.10 18.08% 458.40 418.20 9.61% 484.50 436.90 10.89%
EBITDA 238.50 183.40 30.04% 181.50 159.10 14.08% 173.70 151.00 15.03% 215.10 194.00 10.88%
EBIDTM 31.20% 28.62% 26.88% 27.56% 27.48% 26.53% 30.75% 30.75%
Other Income 29.90 26.30 13.69% 37.00 25.20 46.83% 26.60 31.30 -15.02% 22.80 24.20 -5.79%
Interest 6.10 4.50 35.56% 5.90 4.80 22.92% 7.00 5.10 37.25% 4.60 5.80 -20.69%
Depreciation 40.00 32.80 21.95% 42.70 34.60 23.41% 40.10 33.60 19.35% 38.50 33.40 15.27%
PBT 222.30 172.40 28.94% 169.90 144.90 17.25% 123.10 143.60 -14.28% 194.80 179.00 8.83%
Tax 56.40 43.10 30.86% 28.80 -3.50 - 31.00 38.20 -18.85% 49.10 50.20 -2.19%
PAT 165.90 129.30 28.31% 141.10 148.40 -4.92% 92.10 105.40 -12.62% 145.70 128.80 13.12%
PATM 21.70% 20.18% 20.90% 25.71% 14.57% 18.52% 20.83% 20.42%
EPS 9.90 7.71 28.40% 8.42 8.85 -4.86% 5.50 6.29 -12.56% 8.69 7.68 13.15%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 797.70 669.80 19.10% 702.70 602.60 16.61% 659.80 596.70 10.57% 730.60 660.20 10.66%
Expenses 550.20 477.50 15.23% 515.90 433.60 18.98% 480.50 442.70 8.54% 506.50 457.70 10.66%
EBITDA 247.50 192.30 28.71% 186.80 169.00 10.53% 179.30 154.00 16.43% 224.10 202.50 10.67%
EBIDTM 31.03% 28.71% 26.58% 28.05% 27.17% 25.81% 30.67% 30.67%
Other Income 31.90 28.10 13.52% 24.00 25.80 -6.98% 24.40 25.10 -2.79% 24.80 21.90 13.24%
Interest 6.30 4.70 34.04% 6.10 5.00 22.00% 7.20 5.30 35.85% 4.80 6.00 -20.00%
Depreciation 44.40 34.60 28.32% 44.60 36.40 22.53% 42.10 35.50 18.59% 40.50 35.30 14.73%
PBT 228.70 181.10 26.28% 160.10 153.40 4.37% 124.30 138.30 -10.12% 203.60 183.10 11.20%
Tax 58.20 47.10 23.57% 27.90 -2.10 - 32.90 40.20 -18.16% 51.40 52.30 -1.72%
PAT 170.50 134.00 27.24% 132.20 155.50 -14.98% 91.40 98.10 -6.83% 152.20 130.80 16.36%
PATM 21.37% 20.01% 18.81% 25.80% 13.85% 16.44% 20.83% 19.81%
EPS 10.11 7.90 27.97% 7.83 9.26 -15.44% 5.40 5.78 -6.57% 8.99 7.73 16.30%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,771.30 2,647.57 2,351.61 2,125.06 1,769.03 1,878.79 1,490.56 1,273.60 1,164.90 1,024.04 881.88 Net Sales Growth 14.61% 12.59% 10.66% 20.13% -5.84% 26.05% 17.04% 9.33% 13.76% 16.12% Cost Of Goods Sold 529.70 507.97 455.24 427.87 389.64 447.65 373.90 286.87 254.96 219.31 191.25 Gross Profit 2,241.60 2,139.60 1,896.38 1,697.19 1,379.39 1,431.14 1,116.65 986.73 909.94 804.73 690.63 GP Margin 80.89% 80.81% 80.64% 79.87% 77.97% 76.17% 74.91% 77.48% 78.11% 78.58% 78.31% Total Expenditure 1,962.50 1,893.79 1,686.21 1,544.45 1,308.33 1,366.32 1,083.17 945.79 882.10 767.93 651.76 Power & Fuel Cost - 26.56 25.48 24.47 21.31 19.66 17.18 15.65 14.65 14.40 12.85 % Of Sales - 1.00% 1.08% 1.15% 1.20% 1.05% 1.15% 1.23% 1.26% 1.41% 1.46% Employee Cost - 475.17 431.15 402.57 315.50 321.44 257.44 232.06 201.86 175.09 147.31 % Of Sales - 17.95% 18.33% 18.94% 17.83% 17.11% 17.27% 18.22% 17.33% 17.10% 16.70% Manufacturing Exp. - 520.24 459.58 414.28 358.22 343.63 249.34 217.76 190.60 163.72 134.26 % Of Sales - 19.65% 19.54% 19.49% 20.25% 18.29% 16.73% 17.10% 16.36% 15.99% 15.22% General & Admin Exp. - 310.35 267.01 223.37 182.50 188.78 147.14 156.24 182.56 165.73 139.44 % Of Sales - 11.72% 11.35% 10.51% 10.32% 10.05% 9.87% 12.27% 15.67% 16.18% 15.81% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 53.51 47.75 51.89 41.17 45.16 38.18 37.20 37.47 29.68 0.00 % Of Sales - 2.02% 2.03% 2.44% 2.33% 2.40% 2.56% 2.92% 3.22% 2.90% 3.02% EBITDA 808.80 753.78 665.40 580.61 460.70 512.47 407.39 327.81 282.80 256.11 230.12 EBITDA Margin 29.18% 28.47% 28.30% 27.32% 26.04% 27.28% 27.33% 25.74% 24.28% 25.01% 26.09% Other Income 116.30 112.73 111.52 66.30 46.60 53.10 51.27 57.61 46.49 31.51 28.28 Interest 23.60 22.04 21.50 28.60 34.38 28.63 14.82 14.66 0.74 0.82 0.70 Depreciation 161.30 154.14 134.15 135.79 82.09 75.94 69.78 68.01 36.18 31.05 26.44 PBT 710.10 690.34 621.28 482.53 390.83 460.99 374.04 302.75 292.37 255.76 231.26 Tax 165.30 152.04 124.02 135.80 98.47 115.74 93.94 79.57 96.93 87.49 78.78 Tax Rate 23.28% 23.03% 19.96% 28.14% 25.20% 25.11% 25.11% 26.28% 33.15% 34.21% 34.07% PAT 544.80 508.21 497.27 346.73 292.36 345.25 280.11 223.18 195.44 168.27 152.48 PAT before Minority Interest 544.80 508.21 497.27 346.73 292.36 345.25 280.11 223.18 195.44 168.27 152.48 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.66% 19.20% 21.15% 16.32% 16.53% 18.38% 18.79% 17.52% 16.78% 16.43% 17.29% PAT Growth 6.43% 2.20% 43.42% 18.60% -15.32% 23.26% 25.51% 14.19% 16.15% 10.36% EPS 32.51 30.32 29.67 20.69 17.44 20.60 16.71 13.32 11.66 10.04 9.10

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,890.80 2,762.91 2,461.39 2,226.64 2,016.88 2,087.41 1,581.27 1,330.36 1,203.42 1,056.92 912.38 Net Sales Growth 14.29% 12.25% 10.54% 10.40% -3.38% 32.01% 18.86% 10.55% 13.86% 15.84% Cost Of Goods Sold 557.40 534.62 481.46 451.42 447.15 502.25 397.26 298.70 262.35 226.03 197.08 Gross Profit 2,333.40 2,228.29 1,979.93 1,775.22 1,569.73 1,585.16 1,184.01 1,031.65 941.07 830.89 715.30 GP Margin 80.72% 80.65% 80.44% 79.73% 77.83% 75.94% 74.88% 77.55% 78.20% 78.61% 78.40% Total Expenditure 2,053.10 1,980.39 1,765.80 1,617.40 1,527.05 1,526.68 1,144.99 986.78 909.76 792.92 674.86 Power & Fuel Cost - 28.25 27.16 26.18 25.91 22.11 18.62 16.74 15.74 15.32 13.58 % Of Sales - 1.02% 1.10% 1.18% 1.28% 1.06% 1.18% 1.26% 1.31% 1.45% 1.49% Employee Cost - 503.26 455.78 424.57 376.52 364.94 273.70 242.64 208.29 180.75 152.01 % Of Sales - 18.21% 18.52% 19.07% 18.67% 17.48% 17.31% 18.24% 17.31% 17.10% 16.66% Manufacturing Exp. - 530.86 468.05 423.24 385.55 361.63 257.16 224.87 196.24 166.22 137.24 % Of Sales - 19.21% 19.02% 19.01% 19.12% 17.32% 16.26% 16.90% 16.31% 15.73% 15.04% General & Admin Exp. - 327.60 281.88 236.97 233.04 229.30 157.20 164.31 188.71 174.12 147.72 % Of Sales - 11.86% 11.45% 10.64% 11.55% 10.98% 9.94% 12.35% 15.68% 16.47% 16.19% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 55.80 51.46 55.02 58.88 46.45 41.05 39.51 38.43 30.48 0.00 % Of Sales - 2.02% 2.09% 2.47% 2.92% 2.23% 2.60% 2.97% 3.19% 2.88% 2.98% EBITDA 837.70 782.52 695.59 609.24 489.83 560.73 436.28 343.58 293.66 264.00 237.52 EBITDA Margin 28.98% 28.32% 28.26% 27.36% 24.29% 26.86% 27.59% 25.83% 24.40% 24.98% 26.03% Other Income 105.10 101.27 93.43 69.17 41.72 52.55 51.33 55.05 45.95 31.22 27.54 Interest 24.40 22.80 22.30 29.36 37.53 30.18 16.00 15.31 0.84 0.84 0.70 Depreciation 171.60 161.80 141.92 143.60 150.19 108.11 77.20 72.81 38.22 33.06 27.54 PBT 716.70 699.18 624.80 505.45 343.83 474.98 394.41 310.50 300.55 261.31 236.82 Tax 170.40 159.33 132.55 143.16 102.75 124.69 97.93 82.92 100.08 89.56 81.23 Tax Rate 23.78% 23.81% 21.21% 28.32% 29.88% 26.25% 24.83% 26.71% 33.30% 34.27% 34.30% PAT 546.30 504.78 487.14 357.73 238.85 344.83 291.62 225.94 199.18 170.73 154.59 PAT before Minority Interest 541.90 509.75 492.25 362.29 241.08 350.29 296.48 227.59 200.47 171.75 155.59 Minority Interest -4.40 -4.97 -5.11 -4.56 -2.23 -5.46 -4.86 -1.65 -1.29 -1.02 -1.00 PAT Margin 18.90% 18.27% 19.79% 16.07% 11.84% 16.52% 18.44% 16.98% 16.55% 16.15% 16.94% PAT Growth 5.38% 3.62% 36.18% 49.77% -30.73% 18.25% 29.07% 13.44% 16.66% 10.44% EPS 32.60 30.12 29.07 21.34 14.25 20.57 17.40 13.48 11.88 10.19 9.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,472.83 2,134.23 1,800.72 1,689.86 1,472.12 1,217.09 1,016.28 930.84 776.52 586.44 Share Capital 167.56 83.59 83.48 83.37 83.34 83.34 83.34 83.34 83.33 83.07 Total Reserves 2,239.22 1,994.00 1,666.09 1,548.48 1,331.33 1,093.94 900.05 819.45 675.25 494.83 Non-Current Liabilities 60.43 13.75 53.98 165.59 257.40 76.83 68.18 -19.86 -8.46 -6.00 Secured Loans 0.00 0.00 0.00 83.33 166.67 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 434.44 388.44 450.47 432.16 451.04 252.25 211.29 134.46 111.12 82.58 Trade Payables 175.81 162.70 180.25 140.16 123.47 135.57 112.75 77.17 62.42 50.62 Other Current Liabilities 179.96 178.27 222.09 198.27 208.51 95.89 83.96 39.70 38.86 25.14 Short Term Borrowings 0.00 0.00 0.00 70.00 95.42 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 78.67 47.46 48.13 23.73 23.63 20.78 14.59 17.58 9.84 6.82 Total Liabilities 2,967.70 2,536.42 2,305.17 2,287.61 2,180.56 1,546.17 1,295.75 1,045.44 879.18 663.02 Net Block 1,110.29 1,017.83 1,070.70 361.48 370.95 300.07 296.53 172.96 172.53 120.99 Gross Block 1,979.36 1,740.28 1,666.78 735.64 667.13 520.03 448.96 262.15 226.38 147.43 Accumulated Depreciation 869.07 722.45 596.08 374.16 296.18 219.97 152.43 89.20 53.85 26.44 Non Current Assets 1,473.10 1,259.14 1,268.78 1,477.45 1,481.24 456.86 433.34 249.20 266.42 207.15 Capital Work in Progress 6.53 3.48 5.65 4.94 14.45 8.99 11.29 2.87 9.36 17.20 Non Current Investment 113.94 113.94 112.94 1,072.03 1,061.81 120.40 93.88 32.37 29.71 31.32 Long Term Loans & Adv. 29.29 22.92 27.92 19.89 24.33 23.87 18.43 16.23 14.61 16.11 Other Non Current Assets 180.26 67.62 17.87 19.11 9.71 3.53 13.21 24.77 40.21 21.54 Current Assets 1,494.59 1,277.28 1,036.39 810.17 699.31 1,089.30 862.41 796.23 612.76 455.87 Current Investments 399.31 301.70 100.28 141.38 0.00 50.21 158.89 181.67 143.85 102.96 Inventories 40.60 32.27 32.85 23.34 39.84 38.94 55.00 27.81 26.65 17.14 Sundry Debtors 134.19 105.39 87.47 63.32 67.02 63.54 50.25 53.10 40.18 40.26 Cash & Bank 843.81 767.54 751.67 534.22 542.90 888.63 549.19 478.11 306.78 234.72 Other Current Assets 76.68 49.16 45.91 30.89 49.55 47.98 49.07 55.54 95.29 60.79 Short Term Loans & Adv. 25.05 21.22 18.22 17.03 17.48 16.98 20.13 31.61 80.08 48.24 Net Current Assets 1,060.16 888.85 585.92 378.01 248.28 837.05 651.12 661.77 501.64 373.29 Total Assets 2,967.69 2,536.42 2,305.17 2,287.62 2,180.55 1,546.16 1,295.75 1,045.43 879.18 663.02

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,508.14 2,172.72 1,849.28 1,666.30 1,501.61 1,245.06 1,032.81 945.50 787.85 595.52 Share Capital 167.56 83.59 83.48 83.37 83.34 83.34 83.34 83.34 83.33 83.07 Total Reserves 2,274.53 2,032.48 1,714.65 1,524.67 1,359.98 1,121.91 916.58 834.12 686.58 503.91 Non-Current Liabilities 66.56 21.34 62.16 175.84 272.66 83.01 70.12 -20.25 -8.96 -6.41 Secured Loans 0.00 0.00 0.00 83.33 166.67 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.13 0.12 0.00 0.00 0.00 0.00 Long Term Provisions 2.65 1.95 1.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 450.62 402.35 463.58 469.75 499.99 274.29 227.31 138.30 115.96 84.84 Trade Payables 180.60 167.05 186.57 156.10 147.38 144.13 117.73 79.80 65.45 52.38 Other Current Liabilities 189.17 186.31 227.46 214.02 226.98 108.00 94.03 40.58 40.38 25.37 Short Term Borrowings 0.00 0.00 0.00 70.00 95.42 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 80.85 48.99 49.55 29.63 30.20 22.16 15.55 17.93 10.13 7.09 Total Liabilities 3,058.46 2,630.17 2,411.10 2,345.14 2,309.72 1,633.32 1,351.46 1,069.03 898.64 676.39 Net Block 1,223.57 1,134.99 1,193.83 1,305.06 1,368.81 447.26 413.02 208.66 207.52 152.43 Gross Block 2,146.43 1,903.54 1,828.44 1,807.22 1,726.23 683.53 574.29 301.66 263.71 180.09 Accumulated Depreciation 922.86 768.55 634.62 502.16 357.42 236.27 161.27 93.00 56.19 27.66 Non Current Assets 1,491.97 1,266.66 1,284.41 1,372.05 1,434.56 488.14 458.81 255.41 275.61 209.83 Capital Work in Progress 6.53 3.48 5.65 4.94 15.00 9.61 11.38 3.44 9.56 17.51 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 33.32 26.66 31.26 35.21 39.89 27.14 20.38 16.95 16.26 17.79 Other Non Current Assets 195.76 68.18 19.97 26.84 10.86 4.13 14.03 26.36 42.27 22.09 Current Assets 1,566.49 1,363.51 1,126.70 973.09 875.15 1,145.17 892.65 813.63 623.02 466.56 Current Investments 422.59 326.70 113.78 149.94 65.46 59.30 164.28 184.78 144.80 106.08 Inventories 43.85 36.13 37.31 33.81 52.54 42.56 56.96 28.54 27.34 17.91 Sundry Debtors 110.69 88.12 77.40 70.82 85.39 66.70 51.39 53.22 41.16 41.80 Cash & Bank 909.53 838.68 830.31 665.41 617.59 926.03 569.12 490.24 313.51 239.51 Other Current Assets 79.82 50.88 47.89 34.38 54.17 50.58 50.91 56.85 96.22 61.25 Short Term Loans & Adv. 26.45 23.00 20.01 18.72 20.34 18.82 21.38 32.46 80.76 48.55 Net Current Assets 1,115.88 961.16 663.12 503.33 375.16 870.88 665.34 675.33 507.06 381.72 Total Assets 3,058.46 2,630.17 2,411.11 2,345.14 2,309.71 1,633.31 1,351.46 1,069.04 898.63 676.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 605.87 540.00 504.60 427.53 425.73 373.36 271.99 208.50 189.38 166.67 PBT 660.25 621.28 482.53 390.83 460.99 374.04 302.75 292.37 255.76 152.48 Adjustment 95.22 79.64 120.22 96.31 87.81 59.10 45.84 8.85 17.30 90.08 Changes in Working Capital 17.03 -6.29 29.67 39.52 -5.55 37.33 12.57 9.66 7.86 -7.91 Cash after chg. in Working capital 772.49 694.63 632.42 526.66 543.25 470.47 361.15 310.88 280.92 234.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -166.61 -154.63 -127.82 -99.13 -117.53 -97.12 -89.17 -102.38 -91.53 -67.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -382.09 -293.00 1.17 -288.47 -448.53 -195.19 -19.47 -92.75 -165.90 -134.49 Net Fixed Assets -242.13 -71.33 -931.85 -59.00 -152.56 -68.77 -195.23 -29.28 -71.11 146.62 Net Investments -97.61 -202.42 1,000.19 -151.60 -891.20 82.16 -38.73 -40.48 -39.28 -60.10 Others -42.35 -19.25 -67.17 -77.87 595.23 -208.58 214.49 -22.99 -55.51 -221.01 Cash from Financing Activity -255.95 -324.75 -410.53 -270.05 141.24 -135.74 -187.22 -54.33 12.93 -31.59 Net Cash Inflow / Outflow -32.17 -77.75 95.24 -130.99 118.43 42.42 65.30 61.43 36.41 0.59 Opening Cash & Equivalents 266.60 344.34 249.10 351.31 232.87 189.24 123.95 62.52 26.11 25.38 Closing Cash & Equivalent 234.43 266.60 344.34 220.32 351.31 231.66 189.24 123.95 62.52 25.97

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 635.61 568.88 535.33 456.03 446.69 398.15 283.89 218.54 197.06 171.31 PBT 669.09 624.80 505.45 343.83 474.98 394.41 310.50 300.55 261.31 155.59 Adjustment 115.28 106.86 126.18 183.16 118.45 68.77 54.69 12.96 20.86 94.46 Changes in Working Capital 26.62 1.12 35.74 35.48 -16.71 36.67 12.17 9.30 8.93 -8.13 Cash after chg. in Working capital 810.99 732.78 667.37 562.46 576.72 499.85 377.36 322.81 291.10 241.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -175.38 -163.90 -132.03 -106.43 -130.03 -101.70 -93.47 -104.28 -94.03 -70.61 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -421.86 -303.16 -24.27 -287.31 -449.25 -212.02 -26.11 -99.74 -172.28 -137.11 Net Fixed Assets -242.13 -71.33 -931.85 -59.00 -152.56 -68.77 -195.23 -29.28 -71.11 146.62 Net Investments -97.61 -202.42 1,000.19 -151.60 -891.20 82.16 -38.73 -40.48 -39.28 -60.10 Others -82.12 -29.41 -92.61 -76.71 594.51 -225.41 207.85 -29.98 -61.89 -223.63 Cash from Financing Activity -263.57 -334.03 -413.86 -283.18 136.45 -138.56 -190.44 -55.26 12.51 -32.26 Net Cash Inflow / Outflow -49.83 -68.31 97.20 -114.46 133.90 47.58 67.33 63.54 37.30 1.94 Opening Cash & Equivalents 292.63 360.93 263.73 378.19 244.30 196.72 129.39 65.85 28.55 26.61 Closing Cash & Equivalent 242.80 292.63 360.93 263.73 378.20 244.30 196.72 129.39 65.85 28.55

Financial Ratios

Consolidated /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 143.64 124.27 104.79 195.74 169.74 141.25 117.99 108.32 91.03 69.57 ROA 18.47% 20.54% 15.10% 13.09% 18.53% 19.71% 19.07% 20.31% 21.82% 24.53% ROE 22.67% 25.99% 20.51% 19.19% 26.64% 25.93% 23.66% 23.53% 25.18% 28.87% ROCE 29.62% 31.99% 26.83% 22.71% 32.27% 34.82% 32.60% 34.34% 37.65% 43.53% Fixed Asset Turnover 1.42 1.38 1.77 2.52 3.17 3.08 3.58 4.77 5.48 3.88 Receivable days 16.51 14.97 12.95 13.45 12.68 13.93 14.81 14.61 14.33 15.54 Inventory Days 5.02 5.05 4.83 6.52 7.65 11.50 11.87 8.53 7.80 6.46 Payable days 121.62 137.49 136.66 123.48 105.61 121.20 41.95 36.22 33.95 32.28 Cash Conversion Cycle -100.08 -117.47 -118.89 -103.52 -85.28 -95.77 -15.28 -13.08 -11.82 -10.28 Total Debt/Equity 0.00 0.00 0.05 0.14 0.24 0.00 0.00 0.00 0.00 0.00 Interest Cover 30.96 29.90 17.87 12.37 17.10 26.23 21.65 394.50 314.05 332.31

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 145.75 126.57 107.70 192.88 173.17 144.61 119.97 110.08 92.39 70.66 ROA 17.92% 19.53% 15.23% 10.36% 17.77% 19.87% 18.81% 20.38% 21.81% 24.13% ROE 22.37% 25.15% 21.27% 15.80% 26.45% 26.89% 23.74% 23.76% 25.32% 28.45% ROCE 29.56% 31.53% 27.89% 20.34% 32.67% 36.03% 32.94% 34.78% 37.90% 43.07% Fixed Asset Turnover 1.36 1.32 1.22 1.14 1.73 2.51 3.04 4.26 4.76 3.54 Receivable days 13.13 12.27 12.15 14.14 13.30 13.63 14.35 14.31 14.32 15.62 Inventory Days 5.28 5.45 5.83 7.81 8.31 11.49 11.73 8.47 7.81 6.49 Payable days 118.67 134.04 138.53 123.86 105.92 120.30 41.84 36.52 34.38 32.53 Cash Conversion Cycle -100.26 -116.32 -120.56 -101.91 -84.31 -95.18 -15.76 -13.73 -12.25 -10.42 Total Debt/Equity 0.00 0.00 0.05 0.15 0.24 0.00 0.00 0.00 0.00 0.00 Interest Cover 30.35 29.01 18.22 10.16 16.74 25.65 21.28 359.22 311.72 340.29

Top Investors:

hdfc mutual fund - hdfc retirement savings fund - equity plan

uti-mid cap fund

nippon life india trustee ltd-a/c nippon india pharma fund

smallcap world fund, inc

aditya birla sun life trustee private limited a/c aditya birla sun life small cap fund

life insurance corporation of india

titanium hybrid long-short fund

sbi nifty smallcap 250 etf

invesco oppenheimer international growth fund

Annual Reports:

News Update:

Dr. Lal Pathlabs - Quarterly Results
25th Jul 2026, 00:00 AM

Read More
Dr. Lal Pathlabs incorporates wholly owned subsidiary in Dubai
13th Jun 2026, 12:31 PM

The WOS intends to strategically invest in Diagnostics and allied activities
Read More

Dr. Lal Pathlabs Ltd.

Healthcare Services - Diagnostic

BSE: 539524 | NSE: LALPATHLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Dr. Lal Pathlabs Ltd.

Healthcare Services - Diagnostic

BSE: 539524 | NSE: LALPATHLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: